In Vitro Effects of HAS-2 Gene Silencing on the Proliferation and Apoptosis of the MCF-7 Human Breast Cancer Cell Line

Hongyan Zhang, Liang Feng, Fei Wang, Jianwei Zhang, Li Wang, Xi-Gang Kang, Jie Wang, Qi-Liu DuanCellular 2016 · DOI · OpenAlex

Abstract: Our findings indicate that HAS-2 gene silencing may inhibit proliferation and promote apoptosis in the MCF-7 human breast cancer cell line.

Note: This article has been retracted by the publisher. The following summary describes the study's claims and methodology as originally presented in the publication.

Introduction

Breast cancer remains a leading cause of cancer-related mortality worldwide, largely due to its capacity for tissue invasion and metastasis. A key factor in the tumor microenvironment is the extracellular matrix, where hyaluronan (HA)—a high-molecular-weight polysaccharide—plays a significant role. High levels of HA are frequently associated with malignant progression.

Hyaluronan Synthase 2 (HAS-2) is one of the primary enzymes responsible for synthesizing HA. This study investigated whether silencing the HAS-2 gene could serve as a molecular brake on cancer growth by directly influencing the internal machinery of the cell, specifically the cell cycle and apoptotic pathways.

Methodology

The researchers utilized the MCF-7 human breast cancer cell line to evaluate the impact of HAS-2 silencing.

Gene Silencing and Verification

A "knockdown" approach was employed using small interfering RNA (siRNA) specifically designed to target and degrade HAS-2 mRNA. To verify the efficacy of the silencing, the team used:

  • qRT-PCR: To measure mRNA levels.
  • Western Blotting: To quantify the expression of HAS-2 protein and various apoptosis-related markers, including Caspase-3 and Caspase-9.

Phenotypic Analysis

Several techniques were used to observe the functional consequences of gene silencing:

  • CCK-8 Assay: Quantified cell viability and proliferation at 24, 48, and 72 hours post-transfection.
  • Flow Cytometry: Determined cell cycle distribution (G0/G1, S, or G2/M phases) and calculated the rate of apoptosis.
  • Microscopy: Phase-contrast and Transmission Electron Microscopy (TEM) were used to visualize structural changes, such as chromatin condensation and the formation of apoptotic bodies.

Key Findings

The study revealed that silencing HAS-2 significantly impacts both the morphology and survival of MCF-7 cells.

Morphological Transformation and Growth Inhibition

Silencing HAS-2 caused a dramatic shift in cell appearance. Healthy, spindle-shaped MCF-7 cells transformed into shriveled, granular states with blistering membranes—hallmarks of cell distress and programmed death. Additionally, the ability of single cancer cells to grow into colonies (clones) was remarkably inhibited.

Cell Cycle Arrest

One of the most significant findings was that silencing HAS-2 prevents cells from transitioning from the G1 phase to the S phase, where DNA replication occurs. By trapping cells in the G0/G1 stage, the "engine" of tumor growth is effectively stalled.

Activation of the Caspase Cascade

The study established a clear molecular link between HAS-2 and the caspase cascade. Silencing the gene led to a significant increase in the expression of Caspase-3 and Caspase-9, the enzymes responsible for executing the final stages of apoptosis.

Quantitative Results

  • Successful Knockdown: The HAS-2-siRNA group showed significantly lower mRNA and protein expression compared to control groups ($P < 0.05$).
  • Reduced Viability: At 72 hours, cell viability in the silenced group dropped to approximately 55.53%, compared to 98.84% in the control group.
  • Increased Apoptosis: Flow cytometry revealed a sharp, time-dependent increase in the apoptosis rate in the silenced group.

Discussion and Limitations

While the results suggest that HAS-2 is a critical regulator of tumor cell survival, the authors acknowledge several constraints:

  • In Vitro Scope: The study was conducted entirely in a laboratory setting. The complex physiological environment of a living organism (in vivo) might introduce compensatory mechanisms or different results.
  • Regulatory Complexity: The study demonstrates the effects of silencing but does not fully map the upstream regulatory signals that control HAS-2 expression.
  • Cell Line Specificity: The research focused on the MCF-7 line. Future work is needed to validate these findings across a broader range of breast cancer subtypes and to investigate the interactions between HAS-2, HA, and the CD44 receptor more deeply.

Summary updated

Abstract

Our findings indicate that HAS-2 gene silencing may inhibit proliferation and promote apoptosis in the MCF-7 human breast cancer cell line.
BibTeX
@inproceedings{zhang2016vitro,
  author = {Hongyan Zhang and Liang Feng and Fei Wang and Jianwei Zhang and Li Wang and Xi-Gang Kang and Jie Wang and Qi-Liu Duan},
  title = {{In Vitro Effects of HAS-2 Gene Silencing on the Proliferation and Apoptosis of the MCF-7 Human Breast Cancer Cell Line}},
  booktitle = {Cellular},
  year = {2016},
  doi = {10.1159/000453140},
}

Loading related content...

Figure